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1. Introduction 
People have been relying on natural plants as a source of treatment for various diseases even today that is still the 
case especially in rural areas where traditional healers outnumber western doctors. Most medicines used by western 
doctors are also derived from natural plants. Phytochemicals or secondary metabolites are chemical compounds formed 
during the plants normal metabolic processes and plants use them to protect themselves
1-2
. Free radicals are important 
mediators that provoke inflammatory processes and are neutralized by antioxidant which exerts anti-inflammatory effect
3
. 
Free radical scavenging molecules such as flavonoids, tannins, alkaloids, quinones, amines, vitamins, and other 
metabolites possess anti-inflammatory, anti-carcinogenic, antibacterial and antiviral activities
4
. Most phytochemicals have 
antioxidant activity and protect human cells against oxidative damage. Plants with antioxidants properties are used for 
minimizing the severity of the inflammation related diseases and a health-promoting effect of antioxidants from plants is 
thought to arise from their protective effects by counteracting ROS
5
. 
Philenoptera and Xanthocercis genus both belong to the Fabaceae family
6
. Trees, herbs, vines and schrubs of this 
plant family are native to all regions of the world and are commonly cultivated
7
. Xanthocercis zambesiaca is found in 
Africa and is known as Muchetuchetu/ Musharo in Shona and as Nyala berry in English. Xanthocercis zambesiaca is 
traditionally used to treat diabetes mellitus and has been scientifically proven to have anti-hyperglycemic effects
8
. 
Philenoptera violacea is also found in Africa, known as Mohata in Shona, Mphata in Sotho and as Apple-leaf in English. It 
has been used in traditional remedies to treat gastro-intestinal problems, powdered root-bark for colds and snakebite 
treatment, root infusions as hookworm remedy and most part of the plant has been used to treat diarrhoea
9
 but this plant 
has not yet been investigated for pharmaceutical uses before. In this study, antioxidant potential, anticancer activity and 
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terpenoids, alkaloids and cardiac glycosides from Philenoptera violacea extract, while Xanthocercis zambesiaca extract 
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phytochemical constituents of Philenoptera violacea and Xanthocercis zambesiaca extracts will be determined. 
 
2. Materials and method 
2.1 Plant material 
The plant materials were authenticated by scientists at the National Botanical Gardens in Bloemfontein South 
Africa (MAS002). The collected materials were dried at room temperature and pulverized by mechanical mills and 
weighed. They were then stored in a cool place until analysis. 
2.2 Extraction methods 
Plant materials (10g of the dried leaf, twig and flower) were dried, weighed and soaked in methanol for 72 hours 
with occasional stirring. The extracts were filtered and lyophilized. 
2.3 Scavenging ability towards 2, 2-Diphenyl-1-Picrylhydrazyl (DPPH) radical 
The DPPH assay was performed as described by Shirwaikar
10
. Hundred µl of various concentrations of each 
sample were added to 2 ml solution of 0.1 mM DPPH. Hundred µl of methanol and 2 ml DPPH served as control. After 60 
min of incubation at 25°C in the dark, the absorbance was recorded at 517 nm wavelength. The experiment was performed 
in triplicates. The DPPH radical scavenging activity was calculated according to the following equation: 
% DPPH radical scavenging activity =      (Acontrol  –  Asample) x 100 
           Acontrol 
 
where Asample and Acontrol are absorbance of sample and control. The SC50 (concentration of sample required to 
scavenge 50% of DPPH radicals) values were determined. The decrease of absorbance of DPPH solution indicates an 
increase of the DPPH radical scavenging activity. 
2.4 Anticancer screening 
The growth inhibitory effects of the compounds were tested in the 5-cell line panel consisting of MCF7 (breast 
cancer), HCT116 (colon cancer), TK10 (renal), UACC62 (melanoma) and PC3 (prostate cancer). Cell lines were routinely 
maintained as monolayer cell cultures at 37 °C, 5% CO2 and 100% relative humidity in RPMI containing 5% fetal bovine 
serum, 2mM L-glutamate and 50μg/ml gentamicin. The primary anticancer assay was performed at the CSIR in 
accordance with the protocol of the Drug Evaluation Branch, National Cancer Institute
11-12
. The extracts or compounds 
were tested at a single concentration (100 ppm) and the culture was incubated for 24 h. After 24 h the cells were treated 
with the experimental drugs which were previously dissolved in DMSO and diluted in medium to produce 5 
concentrations.  
The plates were incubated for 48 h after addition of the compounds. Viable cells were fixed to the bottom of each 
well with cold 50% trichloroacetic acid, washed, dried and dyed by SRB. Unbound dye was removed and protein-bound 
dye was extracted with 10mM Tris base for optical density determination at the wavelength 540 nm using a multiwell 
spectrophotometer. Data analysis was performed using GraphPad Prism software 50% of cell growth inhibition (IC50) was 
determined by non-linear regression. The blank contained complete medium without cells and cells without drug addition 
served as control. Parthenolide nd etoposide were used as a standard. 
2.5 Phytochemical analysis 
A small portion of dry extracts were used for the phytochemical tests for compounds which include tannins, 
flavonoids, alkaloids, saponins, terpenoids, steroids and cardiac glycosides
13-15
. 
2.5.1 Test for tannis 
0.2 ml of extract was added to few drops of 1% FeCI3. A green/blue-black colour formed indicated presence of 
tannins. 
2.5.2 Test for flavonoids 
0.1 ml extract was added to 5 ml ammonium hydroxide solution and 3 drops of H2SO4. The formation of a yellow 
colour solution and a white precipitate indicates the presence of flavonoids. 
2.5.3 Test for saponins: 
Foam test: 0.1 ml extract will be shaken vigorously with 3 ml water. The foam formation indicates the presence of 
saponins. 
2.5.4 Test for steroids 
To 2 ml of the extract, 2 ml of chloroform and 2 ml of concentrated H2SO4 was added and then the solution 
shaken well. Presence of steroids is indicated by chloroform (upper) layer turning reddish and the acid layer showing 
yellow colour with greenish fluorescence. 
2.5.5 Test for terpenoids 
1 ml of extract was mixed with 2 ml of chloroform and 2 ml H2SO4 was carefully added to form a layer. A yellow 
layer at the interface indicates presence of terpenoids. 
2.5.6 Test for alkaloids: 
Exactly 0.1 ml extract was added to 1 ml Mayer’s reagent. The solution turning creamy was an indicative of the 
presence of alkaloid. 
2.5.7 Test for cardiac glycosides 
In a test tube, 5ml of the extract was mixed with 2 ml glacial acetic acid, 1 drop of 5% FeCI3 and 1 ml 
concentrated H2SO4. Formation of a brown ring at the interface indicates de-oxysugar characteristic of cardenolides. A 
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violet ring may appear below the brown ring, while in acetic acid layer, a greenish ring may form just gradually throughout 
the thin layer. 
2.6 Determination of total phenolic content 
Total phenols content in the obtained extracts were estimated by a colorimetric assay based on procedures 
described by Singleton and Rossi
16
 with some modifications. Briefly, 1 mL of sample was mixed with 1 mL of Folin and 
Ciocalteu’s phenol reagent. After 3 min, 1 mL of saturated sodium carbonate solution was added to the mixture and 
adjusted to 10 mL with distilled water. The reaction was kept in the dark for 90 min, after which the absorbance was read 
at 725 nm wavelength. Gallic acid was used for constructing the standard curve. The results were expressed as mg of gallic 
acid equivalents/g of extract (GAEs).  
3. Statistical analysis 
All analyses were run in triplicate and the results expressed as mean ± standard deviation (SD). Statistical analysis 
was carried out using the Statistic software Graphpad prism version 5.00. Fifty percent of cell growth inhibition (IC50) was 
determined by non-linear regression and for antioxidant activity a two-tailed test was used and p-values of less than 0.05 
were considered significant.  
 
3. Results  
Figure 1: DPPH scavenging activity of Philenoptera violacea, Xanthocercis zambesiaca extracts and Ascorbic acid 
 
 
The free radical scavenging activities of Philenoptera violacea and Xanthocercis zambesiaca extracts were 
performed using DPPH assay and compared with the scavenging activity of ascorbic acid in figure 1. Ascorbic acid 
showed a high activity with SC50 (68.5%) from a concentration of 0.313 mg/ml. Free radical scavenging activity of 
Philenoptera violacea (19.8%) showed scavenging activity lower than 50% at a high concentration of 2.5 mg/ml. 
Xanthocercis zambesiaca extracts scavenging activity of 50% was at the concentration of 2.5 mg/ml. P values were 
determined using two-tailed test, and for both extracts p < 0.05, thus were statistically significant with Philenoptera 
violacea (p= 0.0010) and Xanthocercis zambesiaca (p= 0.0011). Total phenolic content of Xanthocercis zambesiaca 
extracts (0.0895 ± 0.006 mg/GAE) showed a correlation with the determined antioxidant activity. 
 
Table 1: IC50 of methanol extract of Philenoptera violacea and Xanthocercis zambesiaca on five human cell lines: 
MCF7, HCT116, TK-10, UACC-62 and PC3 against Etoposite and Parthenolide 
 
IC50 MCF7 HCT116 TK-10 UACC-62 PC3 
Philenoptera violacea >100 >100 >100 >100 >100 
Xanthocercis zambesiaca >100 >100 >100 >100 >100 
Etoposide <6.25 19.96 - - 34.64 
Parthenolide <6.25 - <6.25 <6.25 - 
 
Table 2. CSIR criteria 
 
IC50,µg/ml Status 
> 100 µg/ml Inactive 
< 100 µg/ml 
Weak Activity 
>15 µg/ml 
< 15 µg/ml 
Moderate Activity 
> 6.25 µg/ml 
< 6.25 µg/ml Potent Activity 
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The results of five dose screening were reported as 50% of cell growth inhibition (IC50). The biological activities 
were separated into 4 categories: inactive (IC50 >100 µg/ml), weak activity (15 µg/ml < IC50 <100 µg/ml), moderate 
activity (6.25 µg/ml < IC50 <15 µg/ml) and potent activity (IC50 <6.25 µg/ml). According to CSIR criterion (Table 2) both 
samples were considered inactive if parameter IC50 for two or all five cell lines was higher than 100 µg/ml.  Therefore both 
samples can be estimated as inactive against the 5 cell lines. 
 
Table 3: Phytochemical screening of Philenoptera violacea and Xanthocercis zambesiaca extracts 
 
Phytochemical test A B 
Tannins + -- 
Flavonoids + + 
Saponnins -- + 
Steroids + -- 
Terpenoids + + 
Alkaloids + -- 
Cardiac glycosides + + 
+ = present, -- = absent 
A- Philenoptera violacea (leaves, flower & twig)  
B- Xanthocercis zambesiaca (leaves, flower & twig) 
 
The qualitative phytochemical screening above revealed the presence of tannins, flavonoids, steroids, terpenoids, 
alkaloids and cardiac glycosides from Philenoptera violacea (leaves, flower & twig) extract, while Xanthocercis 
zambesiaca (leaves, flower & twig) extract showed the presence of flavonoids, saponnins, terpenoids and glycosides. 
 
Table 4: Total phenolic content of Philenoptera violacea and Xanthocercis zambesiaca extracts 
 
Sample Absorbance Mean Polyphenol concentration (mg/GAE) 
Philenoptera violacea (1 mg/ml) 0.114 0.152 ± 0.0269 
Xanthocercis zambesiaca (1 mg/ml) 0.063 0.0895 ± 0.006 
 
In table 4 are estimated total phenol content values of Philenoptera violacea and Xanthocercis zambesiaca 
extracts which were analysed at 1mg/ml against gallic acid. Philenoptera violacea extracts showed more polyphenols than 
Xanthocercis zambesiaca. The gallic acid equivalents of the estimated phenolic concentrations ranged from 0.152 ± 0.0269 
to 0.0895 ± 0.006 mg/GAE. 
 
5. Discussion 
5.1 Antioxidant Agents 
In normal conditions, the human body possesses many defence mechanisms against oxidative stress, including 
antioxidant enzymes and non-enzymatic compounds. The natural antioxidant mammalian mechanism sometimes become 
insufficient and then the excess of free radicals can damage both the structure and function of a cell membrane in a chain 
reaction leading to many degenerative diseases
17
. Antioxidants reduce the oxidative stress in cells and are therefore useful 
in the treatment of many human diseases, including cancer, cardiovascular diseases and inflammatory diseases. Natural 
plants are a cheap source for the extraction of antioxidant compounds, thus providing important economic advantage. 
The DPPH radical is a stable organic free radical with an absorption maximum band around 515-528 nm. It is therefore a 
useful reagent for evaluation of antioxidant activity of compounds
10
. In the DPPH test, the antioxidants reduce the DPPH 
radical to a yellow-colored compound, diphenylpicrylhydrazine, and the extent of the reaction depends on the hydrogen 
donating ability of the antioxidants. The methanol extract of both Philenoptera violacea and Xanthocercis zambesiaca 
demonstrated a concentration dependent scavenging activity by quenching DPPH radicals. The hydrogen donating activity, 
measured using DPPH test, showed that the concentration of Xanthocercis zambesiaca needed for 50% scavenging (SC50) 
was found to be 2.5 mg/ ml, for Philenoptera violacea was >2.5 mg/ml, whereas <0.313 mg/ml (Figure 1) was needed for 
ascorbic acid. 
5.2 Anticancer screening 
Cancer is one of the most prominent diseases in humans. Plants still remain a prime source of drugs for the 
treatment of cancer and can provide leads for the development of novel anticancer agents. The pace of research in the 
continuing discovery of new anticancer agents from natural product sources has been staggering lately
18
. Recently, 
intensive research has been focused on developing tumor therapies from saponins. Xanthocercis zambesiaca extract had 
saponins and glycosides. Saponins exhibits potent anticancer activity in several human cancer cells through apoptosis-
inducing pathways
19
 and glycosides are compounds that strongly influences the anticancer activity of the plant extract
20
.  
According to CSIR criteria shown in Table 2, both Philenoptera violacea and Xanthocercis zambesiaca extracts can be 
estimated as inactive (Table 1) against 5 selected cell lines. Xanthocercis zambesiaca have been proven to have 
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Isoflavones
21
 and this compound regulates estrogen levels. As it is known that estrogen reduced risks of ovarian and 
endometrial cancer
22-23
, anticancer screening on these cell lines might show some positive results. The obtained results 
have stimulated us to carry out on-going work to determine the anticancer activity against other cell lines. 
5.3 Phytochemical properties 
The medicinal values of plants lie in their component phytochemicals such as alkaloids, tannins, flavonoids and 
other phenolic compounds, which produce a definite physiological action on the human body
24
. Phytochemical screening 
of Philenoptera violacea extract showed the presence of tannins, flavonoids, steroids, terpenoids, alkaloids and cardiac 
glycosides, while Xanthocercis zambesiaca extract showed the presence of flavonoids, saponnins, terpenoids and 
glycosides (Table 3). The beneficial health effects of plants are attributed to flavonoids, a class of secondary metabolites 
which protect the plant against ultraviolet light and even herbivores
25
. The protective effects of flavonoids are due to their 
capacity to transfer electrons to free radicals. Alkaloids and their synthetic derivatives are used as basic medicinal agents 
for their antispasmodic and bactericidal effects
26-27
. Alkaloids in Xanthocercis zambesiaca may be responsible for its 
antibacterial effect
28
. Tannins in Philenoptera violacea have astringent properties, hastens the healing of wounds 
(snakebite) and inflamed mucous membranes (due to tuberculosis/ colds)
9
. The phenolic compounds are commonly found 
in the plant kingdom, and they have been reported to have multiple biological effects including antioxidant activity
29
. 
We therefore conclude that Xanthocercis zambesiaca exhibited a moderate dose dependent antioxidant activity and is 
correlated with polyphenolic content of this plant extract. Both Philenoptera violacea and Xanthocercis zambesiaca 
extracts showed no anticancer activity against human cell lines: MCF7, HCT116, TK-10, UACC-62 and PC3. 
Philenoptera violacea extracts showed more polyphenols and phytochemical contents than Xanthocercis zambesiaca but 
this did not correlate with its antioxidant activity. Further testing using other cell lines is required and also to identify the 
active compounds of both Philenoptera violacea and Xanthocercis zambesiaca.  
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